Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor ProgressionXiaoming Li, H Michael Shepard, Jessica A Cowell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumorsGayle S Jameson, John T Hamm, Glen J Weiss, et al.
The New England Journal of Medicine|September 4, 2009
Inhibition of the hedgehog pathway in advanced basal-cell carcinomaDaniel D Von Hoff, Patricia M LoRusso, Charles M Rudin, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Breast Cancer Research and Treatment|September 12, 2014
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle S Jameson, Emanuel F Petricoin, Jasgit Sachdev, et al.
Med (New York, N.Y.)|July 5, 2021
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancerJonathan M Ghergurovich, Jessica D Lang, Maren K Levin, et al.
Lancet (London, England)|November 30, 2015
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trialAndrea Wang-Gillam, Chung-Pin Li, György Bodoky, et al.
Science Translational Medicine|February 18, 2021
Analysis of recurrently protected genomic regions in cell-free DNA found in urineHavell Markus, Jun Zhao, Tania Contente-Cuomo, et al.
Cell Chemical Biology|August 2, 2023
Small molecule targeting of transcription-replication conflict for selective chemotherapyLong Gu, Min Li, Caroline M Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancerColin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.
Pageof 22